Paul Dellorusso

Paul Dellorusso is an investment professional with a strong background in equity analysis and private equity, currently serving as an Analyst at Acuta Capital Partners LLC in New York, NY. His expertise spans the healthcare and life sciences sectors, leveraging his advanced scientific training and financial acumen to evaluate investment opportunities in these dynamic industries. At Acuta Capital Partners, Dellorusso is responsible for conducting in-depth research, performing financial modeling, and supporting investment decisions for the firm's equity portfolios, with a particular focus on healthcare and biotechnology companies.

Dellorusso's investment focus is centered on the healthcare sector, including biotechnology, pharmaceuticals, and medical devices. His role involves analyzing market trends, assessing company fundamentals, and identifying high-potential investment opportunities within these specialized areas. His background in cellular, molecular, and biomedical sciences provides him with a unique perspective on the technical and scientific aspects of healthcare investments, enabling him to make informed recommendations and contribute to the firm's investment strategy.

Prior to joining Acuta Capital Partners, Dellorusso was an Associate at Mérieux Equity Partners SAS, a private equity and venture capital firm specializing in healthcare investments. He holds a Doctor of Philosophy (Ph.D.) in Cellular, Molecular, and Biomedical Sciences from Columbia University Medical Center and a Bachelor of Arts (B.A.) in Biology from Dartmouth College. Dellorusso's interdisciplinary expertise in science and finance has allowed him to bridge the gap between technical innovation and investment analysis, making significant contributions to the healthcare investment landscape.